0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Wearable Injectors and Connected Devices Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-7N10849
Home | Market Reports | Health| Medical Devices & Equipment
Global Wearable Injectors and Connected Devices Market Research Report 2022
BUY CHAPTERS

Global Wearable Injectors and Connected Devices Market Research Report 2025

Code: QYRE-Auto-7N10849
Report
March 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wearable Injectors and Connected Devices Market

The global market for Wearable Injectors and Connected Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Wearable Injectors and Connected Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Wearable Injectors and Connected Devices include Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation, West Pharma, Eitan Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wearable Injectors and Connected Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Injectors and Connected Devices.
The Wearable Injectors and Connected Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wearable Injectors and Connected Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Injectors and Connected Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Wearable Injectors and Connected Devices Market Report

Report Metric Details
Report Name Wearable Injectors and Connected Devices Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation, West Pharma, Eitan Medical, BD Medical, Noble International, Insulet, Amgen, Roche, CeQur, ScPharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Wearable Injectors and Connected Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Wearable Injectors and Connected Devices Market report?

Ans: The main players in the Wearable Injectors and Connected Devices Market are Gerresheimer, Owen Mumford, Sonceboz, United Therapeutics, Ypsomed, Elcam Medical, Enable Injections, Unilife Corporation, West Pharma, Eitan Medical, BD Medical, Noble International, Insulet, Amgen, Roche, CeQur, ScPharmaceuticals

What are the Application segmentation covered in the Wearable Injectors and Connected Devices Market report?

Ans: The Applications covered in the Wearable Injectors and Connected Devices Market report are Hospitals, Clinics, Home Care Settings, Others

What are the Type segmentation covered in the Wearable Injectors and Connected Devices Market report?

Ans: The Types covered in the Wearable Injectors and Connected Devices Market report are Disposable, Reusable

Recommended Reports

Wearable Healthcare Devices

Connected Medical Devices

Wearable Sensors & Monitoring

1 Wearable Injectors and Connected Devices Market Overview
1.1 Product Definition
1.2 Wearable Injectors and Connected Devices by Type
1.2.1 Global Wearable Injectors and Connected Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Disposable
1.2.3 Reusable
1.3 Wearable Injectors and Connected Devices by Application
1.3.1 Global Wearable Injectors and Connected Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Settings
1.3.5 Others
1.4 Global Wearable Injectors and Connected Devices Market Size Estimates and Forecasts
1.4.1 Global Wearable Injectors and Connected Devices Revenue 2020-2031
1.4.2 Global Wearable Injectors and Connected Devices Sales 2020-2031
1.4.3 Global Wearable Injectors and Connected Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Wearable Injectors and Connected Devices Market Competition by Manufacturers
2.1 Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Wearable Injectors and Connected Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Wearable Injectors and Connected Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application
2.7 Global Key Manufacturers of Wearable Injectors and Connected Devices, Date of Enter into This Industry
2.8 Global Wearable Injectors and Connected Devices Market Competitive Situation and Trends
2.8.1 Global Wearable Injectors and Connected Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Wearable Injectors and Connected Devices Players Market Share by Revenue
2.8.3 Global Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Wearable Injectors and Connected Devices Market Scenario by Region
3.1 Global Wearable Injectors and Connected Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Wearable Injectors and Connected Devices Sales by Region: 2020-2031
3.2.1 Global Wearable Injectors and Connected Devices Sales by Region: 2020-2025
3.2.2 Global Wearable Injectors and Connected Devices Sales by Region: 2026-2031
3.3 Global Wearable Injectors and Connected Devices Revenue by Region: 2020-2031
3.3.1 Global Wearable Injectors and Connected Devices Revenue by Region: 2020-2025
3.3.2 Global Wearable Injectors and Connected Devices Revenue by Region: 2026-2031
3.4 North America Wearable Injectors and Connected Devices Market Facts & Figures by Country
3.4.1 North America Wearable Injectors and Connected Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Wearable Injectors and Connected Devices Sales by Country (2020-2031)
3.4.3 North America Wearable Injectors and Connected Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wearable Injectors and Connected Devices Market Facts & Figures by Country
3.5.1 Europe Wearable Injectors and Connected Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Wearable Injectors and Connected Devices Sales by Country (2020-2031)
3.5.3 Europe Wearable Injectors and Connected Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Injectors and Connected Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Wearable Injectors and Connected Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Wearable Injectors and Connected Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Wearable Injectors and Connected Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wearable Injectors and Connected Devices Market Facts & Figures by Country
3.7.1 Latin America Wearable Injectors and Connected Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Wearable Injectors and Connected Devices Sales by Country (2020-2031)
3.7.3 Latin America Wearable Injectors and Connected Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Injectors and Connected Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Injectors and Connected Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wearable Injectors and Connected Devices Sales by Type (2020-2031)
4.1.1 Global Wearable Injectors and Connected Devices Sales by Type (2020-2025)
4.1.2 Global Wearable Injectors and Connected Devices Sales by Type (2026-2031)
4.1.3 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2020-2031)
4.2 Global Wearable Injectors and Connected Devices Revenue by Type (2020-2031)
4.2.1 Global Wearable Injectors and Connected Devices Revenue by Type (2020-2025)
4.2.2 Global Wearable Injectors and Connected Devices Revenue by Type (2026-2031)
4.2.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2020-2031)
4.3 Global Wearable Injectors and Connected Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Wearable Injectors and Connected Devices Sales by Application (2020-2031)
5.1.1 Global Wearable Injectors and Connected Devices Sales by Application (2020-2025)
5.1.2 Global Wearable Injectors and Connected Devices Sales by Application (2026-2031)
5.1.3 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2020-2031)
5.2 Global Wearable Injectors and Connected Devices Revenue by Application (2020-2031)
5.2.1 Global Wearable Injectors and Connected Devices Revenue by Application (2020-2025)
5.2.2 Global Wearable Injectors and Connected Devices Revenue by Application (2026-2031)
5.2.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2020-2031)
5.3 Global Wearable Injectors and Connected Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gerresheimer
6.1.1 Gerresheimer Company Information
6.1.2 Gerresheimer Description and Business Overview
6.1.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
6.1.5 Gerresheimer Recent Developments/Updates
6.2 Owen Mumford
6.2.1 Owen Mumford Company Information
6.2.2 Owen Mumford Description and Business Overview
6.2.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
6.2.5 Owen Mumford Recent Developments/Updates
6.3 Sonceboz
6.3.1 Sonceboz Company Information
6.3.2 Sonceboz Description and Business Overview
6.3.3 Sonceboz Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
6.3.5 Sonceboz Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 Ypsomed
6.5.1 Ypsomed Company Information
6.5.2 Ypsomed Description and Business Overview
6.5.3 Ypsomed Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
6.5.5 Ypsomed Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Company Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Enable Injections
6.7.1 Enable Injections Company Information
6.7.2 Enable Injections Description and Business Overview
6.7.3 Enable Injections Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
6.7.5 Enable Injections Recent Developments/Updates
6.8 Unilife Corporation
6.8.1 Unilife Corporation Company Information
6.8.2 Unilife Corporation Description and Business Overview
6.8.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
6.8.5 Unilife Corporation Recent Developments/Updates
6.9 West Pharma
6.9.1 West Pharma Company Information
6.9.2 West Pharma Description and Business Overview
6.9.3 West Pharma Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
6.9.5 West Pharma Recent Developments/Updates
6.10 Eitan Medical
6.10.1 Eitan Medical Company Information
6.10.2 Eitan Medical Description and Business Overview
6.10.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
6.10.5 Eitan Medical Recent Developments/Updates
6.11 BD Medical
6.11.1 BD Medical Company Information
6.11.2 BD Medical Description and Business Overview
6.11.3 BD Medical Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
6.11.5 BD Medical Recent Developments/Updates
6.12 Noble International
6.12.1 Noble International Company Information
6.12.2 Noble International Description and Business Overview
6.12.3 Noble International Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
6.12.5 Noble International Recent Developments/Updates
6.13 Insulet
6.13.1 Insulet Company Information
6.13.2 Insulet Description and Business Overview
6.13.3 Insulet Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
6.13.5 Insulet Recent Developments/Updates
6.14 Amgen
6.14.1 Amgen Company Information
6.14.2 Amgen Description and Business Overview
6.14.3 Amgen Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
6.14.5 Amgen Recent Developments/Updates
6.15 Roche
6.15.1 Roche Company Information
6.15.2 Roche Description and Business Overview
6.15.3 Roche Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Roche Wearable Injectors and Connected Devices Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 CeQur
6.16.1 CeQur Company Information
6.16.2 CeQur Description and Business Overview
6.16.3 CeQur Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
6.16.5 CeQur Recent Developments/Updates
6.17 ScPharmaceuticals
6.17.1 ScPharmaceuticals Company Information
6.17.2 ScPharmaceuticals Description and Business Overview
6.17.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
6.17.5 ScPharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Injectors and Connected Devices Industry Chain Analysis
7.2 Wearable Injectors and Connected Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Injectors and Connected Devices Production Mode & Process Analysis
7.4 Wearable Injectors and Connected Devices Sales and Marketing
7.4.1 Wearable Injectors and Connected Devices Sales Channels
7.4.2 Wearable Injectors and Connected Devices Distributors
7.5 Wearable Injectors and Connected Devices Customer Analysis
8 Wearable Injectors and Connected Devices Market Dynamics
8.1 Wearable Injectors and Connected Devices Industry Trends
8.2 Wearable Injectors and Connected Devices Market Drivers
8.3 Wearable Injectors and Connected Devices Market Challenges
8.4 Wearable Injectors and Connected Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Wearable Injectors and Connected Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Wearable Injectors and Connected Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Wearable Injectors and Connected Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Wearable Injectors and Connected Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Wearable Injectors and Connected Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Wearable Injectors and Connected Devices Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Wearable Injectors and Connected Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Wearable Injectors and Connected Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Wearable Injectors and Connected Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Wearable Injectors and Connected Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Wearable Injectors and Connected Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Injectors and Connected Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Wearable Injectors and Connected Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Wearable Injectors and Connected Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Wearable Injectors and Connected Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Wearable Injectors and Connected Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Wearable Injectors and Connected Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Wearable Injectors and Connected Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Wearable Injectors and Connected Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Wearable Injectors and Connected Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Wearable Injectors and Connected Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Wearable Injectors and Connected Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Wearable Injectors and Connected Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Wearable Injectors and Connected Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Wearable Injectors and Connected Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Wearable Injectors and Connected Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Wearable Injectors and Connected Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Wearable Injectors and Connected Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Wearable Injectors and Connected Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Wearable Injectors and Connected Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Wearable Injectors and Connected Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Wearable Injectors and Connected Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Wearable Injectors and Connected Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Wearable Injectors and Connected Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Wearable Injectors and Connected Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Wearable Injectors and Connected Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Wearable Injectors and Connected Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Wearable Injectors and Connected Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Wearable Injectors and Connected Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Wearable Injectors and Connected Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Wearable Injectors and Connected Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Wearable Injectors and Connected Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Wearable Injectors and Connected Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Wearable Injectors and Connected Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Wearable Injectors and Connected Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Application (2026-2031)
 Table 70. Gerresheimer Company Information
 Table 71. Gerresheimer Description and Business Overview
 Table 72. Gerresheimer Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gerresheimer Wearable Injectors and Connected Devices Product
 Table 74. Gerresheimer Recent Developments/Updates
 Table 75. Owen Mumford Company Information
 Table 76. Owen Mumford Description and Business Overview
 Table 77. Owen Mumford Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Owen Mumford Wearable Injectors and Connected Devices Product
 Table 79. Owen Mumford Recent Developments/Updates
 Table 80. Sonceboz Company Information
 Table 81. Sonceboz Description and Business Overview
 Table 82. Sonceboz Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sonceboz Wearable Injectors and Connected Devices Product
 Table 84. Sonceboz Recent Developments/Updates
 Table 85. United Therapeutics Company Information
 Table 86. United Therapeutics Description and Business Overview
 Table 87. United Therapeutics Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. United Therapeutics Wearable Injectors and Connected Devices Product
 Table 89. United Therapeutics Recent Developments/Updates
 Table 90. Ypsomed Company Information
 Table 91. Ypsomed Description and Business Overview
 Table 92. Ypsomed Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Ypsomed Wearable Injectors and Connected Devices Product
 Table 94. Ypsomed Recent Developments/Updates
 Table 95. Elcam Medical Company Information
 Table 96. Elcam Medical Description and Business Overview
 Table 97. Elcam Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Elcam Medical Wearable Injectors and Connected Devices Product
 Table 99. Elcam Medical Recent Developments/Updates
 Table 100. Enable Injections Company Information
 Table 101. Enable Injections Description and Business Overview
 Table 102. Enable Injections Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Enable Injections Wearable Injectors and Connected Devices Product
 Table 104. Enable Injections Recent Developments/Updates
 Table 105. Unilife Corporation Company Information
 Table 106. Unilife Corporation Description and Business Overview
 Table 107. Unilife Corporation Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Unilife Corporation Wearable Injectors and Connected Devices Product
 Table 109. Unilife Corporation Recent Developments/Updates
 Table 110. West Pharma Company Information
 Table 111. West Pharma Description and Business Overview
 Table 112. West Pharma Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. West Pharma Wearable Injectors and Connected Devices Product
 Table 114. West Pharma Recent Developments/Updates
 Table 115. Eitan Medical Company Information
 Table 116. Eitan Medical Description and Business Overview
 Table 117. Eitan Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Eitan Medical Wearable Injectors and Connected Devices Product
 Table 119. Eitan Medical Recent Developments/Updates
 Table 120. BD Medical Company Information
 Table 121. BD Medical Description and Business Overview
 Table 122. BD Medical Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BD Medical Wearable Injectors and Connected Devices Product
 Table 124. BD Medical Recent Developments/Updates
 Table 125. Noble International Company Information
 Table 126. Noble International Description and Business Overview
 Table 127. Noble International Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Noble International Wearable Injectors and Connected Devices Product
 Table 129. Noble International Recent Developments/Updates
 Table 130. Insulet Company Information
 Table 131. Insulet Description and Business Overview
 Table 132. Insulet Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Insulet Wearable Injectors and Connected Devices Product
 Table 134. Insulet Recent Developments/Updates
 Table 135. Amgen Company Information
 Table 136. Amgen Description and Business Overview
 Table 137. Amgen Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Amgen Wearable Injectors and Connected Devices Product
 Table 139. Amgen Recent Developments/Updates
 Table 140. Roche Company Information
 Table 141. Roche Description and Business Overview
 Table 142. Roche Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Roche Wearable Injectors and Connected Devices Product
 Table 144. Roche Recent Developments/Updates
 Table 145. CeQur Company Information
 Table 146. CeQur Description and Business Overview
 Table 147. CeQur Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. CeQur Wearable Injectors and Connected Devices Product
 Table 149. CeQur Recent Developments/Updates
 Table 150. ScPharmaceuticals Company Information
 Table 151. ScPharmaceuticals Description and Business Overview
 Table 152. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. ScPharmaceuticals Wearable Injectors and Connected Devices Product
 Table 154. ScPharmaceuticals Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Wearable Injectors and Connected Devices Distributors List
 Table 158. Wearable Injectors and Connected Devices Customers List
 Table 159. Wearable Injectors and Connected Devices Market Trends
 Table 160. Wearable Injectors and Connected Devices Market Drivers
 Table 161. Wearable Injectors and Connected Devices Market Challenges
 Table 162. Wearable Injectors and Connected Devices Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Wearable Injectors and Connected Devices
 Figure 2. Global Wearable Injectors and Connected Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Wearable Injectors and Connected Devices Market Share by Type: 2024 & 2031
 Figure 4. Disposable Product Picture
 Figure 5. Reusable Product Picture
 Figure 6. Global Wearable Injectors and Connected Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Wearable Injectors and Connected Devices Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Home Care Settings
 Figure 11. Others
 Figure 12. Global Wearable Injectors and Connected Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Wearable Injectors and Connected Devices Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Wearable Injectors and Connected Devices Sales (2020-2031) & (K Units)
 Figure 15. Global Wearable Injectors and Connected Devices Average Price (US$/Unit) & (2020-2031)
 Figure 16. Wearable Injectors and Connected Devices Report Years Considered
 Figure 17. Wearable Injectors and Connected Devices Sales Share by Manufacturers in 2024
 Figure 18. Global Wearable Injectors and Connected Devices Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Wearable Injectors and Connected Devices Players: Market Share by Revenue in Wearable Injectors and Connected Devices in 2024
 Figure 20. Wearable Injectors and Connected Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Wearable Injectors and Connected Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2020-2031)
 Figure 23. North America Wearable Injectors and Connected Devices Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2020-2031)
 Figure 27. Europe Wearable Injectors and Connected Devices Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Wearable Injectors and Connected Devices Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Wearable Injectors and Connected Devices Revenue Market Share by Region (2020-2031)
 Figure 35. China Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Wearable Injectors and Connected Devices Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Wearable Injectors and Connected Devices Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Wearable Injectors and Connected Devices Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Wearable Injectors and Connected Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Wearable Injectors and Connected Devices by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Wearable Injectors and Connected Devices by Type (2020-2031)
 Figure 57. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Wearable Injectors and Connected Devices by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Wearable Injectors and Connected Devices by Application (2020-2031)
 Figure 60. Global Wearable Injectors and Connected Devices Price (US$/Unit) by Application (2020-2031)
 Figure 61. Wearable Injectors and Connected Devices Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart